The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Eisenberg, Mark J
  • Windle, Sarah B
  • Roy, Nathalie
  • Old, Wayne
  • Grondin, Franois
  • Bata, Iqbal
  • Iskander, Ayman
  • lauzon, Claude
  • Srivastava, Nalin
  • Clarke, Adam
  • Cassavar, Daniel
  • Dion, Danielle
  • Haught, Herbert
  • Mehta, Shamir
  • Baril, Jean-Francois
  • Lambert, Charles
  • Madan, Mina
  • Abramson, Beth L
  • Dehghani, Payam

publication date

  • December 8, 2015